Dominick & Dominick’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
$1.26M Buy
42,690
+996
+2% +$28.6K 0.64% 42
2014
Q3
$1.17M Buy
41,694
+20,466
+96% +$574K 0.56% 50
2014
Q2
$598K Sell
21,228
-7,268
-26% -$207K 0.29% 98
2014
Q1
$868K Buy
28,496
+1,909
+7% +$56.9K 0.42% 72
2013
Q4
$773K Sell
26,587
-94
-0.4% -$2.74K 0.37% 80
2013
Q3
$727K Buy
26,681
+12,533
+89% +$341K 0.4% 79
2013
Q2
$376K Buy
+14,148
New +$391K 0.22% 118

Other funds holding PFE

Dominick & Dominick's PFE Position: Q4 2014 in Review

Dominick & Dominick increased its Pfizer (PFE) stake by 2.4% in Q4 2014, buying an estimated $28.6K and bringing the position to 42,690 shares worth $1.26M. The position accounts for 0.64% of the portfolio, ranked #42.

Dominick & Dominick first reported a position in PFE in Q2 2013 and has held it in 7 quarters since. 1,860 funds tracked by Wall St. Rank hold PFE as of Q4 2014.

  • Dominick & Dominick held 42,690 shares of Pfizer worth $1.26M as of Q4 2014.
  • Dominick & Dominick bought 996 Pfizer shares in Q4 2014, an estimated $28.6K.
  • Pfizer made up 0.64% of Dominick & Dominick's portfolio in Q4 2014, its #42 holding.
  • Dominick & Dominick first reported a position in Pfizer in Q2 2013 and has held it in 7 quarters since.
  • 1,860 funds tracked by Wall St. Rank held Pfizer as of Q4 2014.

Based on Dominick & Dominick's 13F filing for Q4 2014, filed 22 Jan 2015.